Portfolio / Galápagos

Galapagos.gif


Galápagos is a clinical-stage biotechnology company, specialized in the development of small molecule medicines with novel modes of action.

They try to discover which proteins (‘targets’) play a key role in causing diseases such as rheumatoid arthritis, inflammatory bowel disease and fibrosis by using human primary cells and patient cells. The company is listed on Euronext and NASDAQ.

Website

Company: galápagos

Fund: alpinvest

Status: Realized

Team member:

Harrold van Barlingen

19.jpg
 

Technology:

Therapeutics

Icons-Creteria_Medical-technologymedical-devices.png